TY - JOUR
T1 - STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemia
AU - Fischer, Alexander
AU - Hernandez-Rodriguez, Benjamin
AU - Mulet-Lazaro, Roger
AU - Nuetzel, Margit
AU - Hoelzl, Fabian
AU - van Herk, Stanley
AU - Kavelaars, Francois G.
AU - Stanewsky, Hanna
AU - Ackermann, Ute
AU - Niang, Amadou H.
AU - Diaz, Noelia
AU - Reuschel, Edith
AU - Strieder, Nicholas
AU - Hernandez-Lopez, Inmaculada
AU - Valk, Peter J. M.
AU - Vaquerizas, Juan M.
AU - Rehli, Michael
AU - Delwel, Ruud
AU - Gebhard, Claudia
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2024/8/27
Y1 - 2024/8/27
N2 - Cohesin shapes the chromatin architecture, including enhancer-promoter interactions. Its components, especially STAG2, but not its paralog STAG1, are frequently mutated in myeloid malignancies. To elucidate the underlying mechanisms of leukemogenesis, we comprehensively characterized genetic, transcriptional, and chromatin conformational changes in acute myeloid leukemia (AML) patient samples. Specific loci displayed altered cohesin occupancy, gene expression, and local chromatin activation, which were not compensated by the remaining STAG1-cohesin. These changes could be linked to disrupted spatial chromatin looping in cohesin-mutated AMLs. Complementary depletion of STAG2 or STAG1 in primary human hematopoietic progenitors (HSPCs) revealed effects resembling STAG2-mutant AML-specific changes following STAG2 knockdown, not invoked by the depletion of STAG1. STAG2-deficient HSPCs displayed impaired differentiation capacity and maintained HSPC-like gene expression. This work establishes STAG2 as a key regulator of chromatin contacts, gene expression, and differentiation in the hematopoietic system and identifies candidate target genes that may be implicated in human leukemogenesis.
AB - Cohesin shapes the chromatin architecture, including enhancer-promoter interactions. Its components, especially STAG2, but not its paralog STAG1, are frequently mutated in myeloid malignancies. To elucidate the underlying mechanisms of leukemogenesis, we comprehensively characterized genetic, transcriptional, and chromatin conformational changes in acute myeloid leukemia (AML) patient samples. Specific loci displayed altered cohesin occupancy, gene expression, and local chromatin activation, which were not compensated by the remaining STAG1-cohesin. These changes could be linked to disrupted spatial chromatin looping in cohesin-mutated AMLs. Complementary depletion of STAG2 or STAG1 in primary human hematopoietic progenitors (HSPCs) revealed effects resembling STAG2-mutant AML-specific changes following STAG2 knockdown, not invoked by the depletion of STAG1. STAG2-deficient HSPCs displayed impaired differentiation capacity and maintained HSPC-like gene expression. This work establishes STAG2 as a key regulator of chromatin contacts, gene expression, and differentiation in the hematopoietic system and identifies candidate target genes that may be implicated in human leukemogenesis.
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:001306618600001&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.1016/j.celrep.2024.114498
DO - 10.1016/j.celrep.2024.114498
M3 - Article
C2 - 39084219
SN - 2211-1247
VL - 43
JO - Cell Reports
JF - Cell Reports
IS - 8
M1 - 114498
ER -